BRATISLAVA, Slovakia--(BUSINESS WIRE)--Biotech company AXON Neuroscience, which is currently a driving force in the development of disease modifying treatments for Alzheimer’s disease(AD), is pleased to announce that Prof. Michal Novak, has been appointed as a Chairman of the Scientific Advisory Board of AXON Neuroscience , effective from October 1, 2015. Assoc. Prof. Norbert Zilka, previously AXON’s Head of Preclinical Trials, was named the company’s new Chief Science Officer.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
